I will tell you why I think NP's timelines were un

I will tell you why I think NP's timelines were unrealistic from the start.

An experienced CEO of a fledgling biotech would probably have known that there are often customs delays to deal with.

An experienced CEO of a fledgling biotech would probably have known that case numbers were actually dwindling which could cause a delay in enrollment.

An experienced CEO of a fledgling biotech would probably have known that there are often unforeseen delays in all trials.

An experienced CEO of a fledgling biotech would probably have known that it is better to be conservative and under promise and over deliver than to give a "best case scenario" timeline to investors instead of managing their expectations in a more rational and less emotional manner.

And NO, NP did NOT "have to say something" other than "We are very excited to be working with BIOMM to set up this next trial and are hopeful that the results are what we all believe they will be and we will update you as to progress in due time." BOOM! Yes, it IS just that easy.